Calpains, a family of Ca 2+ -dependent cytosolic cysteine proteases, can modulate their substrates' structure and function through limited proteolytic activity. In the human genome, there are 15 calpain genes. The most-studied calpains, referred to as conventional calpains, are ubiquitous. While genetic studies in mice have improved our understanding about the conventional calpains' physiological functions, especially those essential for mammalian life as in embryogenesis, many reports have pointed to overactivated conventional calpains as an exacerbating factor in pathophysiological conditions such as cardiovascular diseases and muscular dystrophies. For treatment of these diseases, calpain inhibitors have always been considered as drug targets. Recent studies have introduced another aspect of calpains that calpain activity is required to protect the heart and skeletal muscle against stress. This review summarizes the functions and regulation of calpains, focusing on the relevance of calpains to cardiovascular disease.
Introduction
Calpains 1 -4 (Clan CA, family C02; EC 3.4.22.17) are defined by their amino acid (aa) sequence similar to the calpain-like Cys protease motif CysPc, which is registered as cd00044 in the National Center for Biotechnology Information's conserved domain database. Using this criterion, the database identifies calpain homologues in a wide range of living organisms. The physiological relevance of calpains has been elusive, partly because each calpain species is fairly specific in its function as a critical regulator for cellular functions. On the other hand, calpains are often described as aggravating factors in various pathophysiological phenomena; 5 -11 therefore, inhibiting calpains is an established research interest. Although little has been elucidated about when and how calpain is activated, fortunately, a new perspective emerges. Improved genetic techniques have revealed cause-and-effect relationships between calpain deficiencies and dysfunctions of tissues and organs. 12 These calpain-deficiency diseases, which should generally be called calpainopathies, provide clear evidence of the physiological importance of calpains. Although calpains have frequently been characterized as deleterious degradative proteases in pathogenic conditions including cardiovascular diseases, calpains are actually processing rather than degradative proteases. Calpains differ from other major intracellular proteolytic components such as proteasomes 13 and lysosomal proteases functioning in autophagy; 14 these systems eliminate and recycle their substrates by degradation. Calpains act by proteolytic processing, as in the activation of conventional protein kinase C (PKC) (see Section 5.2.1). Calpains are unique in that they directly recognize substrates, whereas proteasomes and autophagy rely on other systems-ubiquitylation and autophagosome formation, respectively-to tag their substrates ( Figure 1) . After a brief overview of the molecules that comprise the calpain system, we will review calpains' activation mechanisms and physiological and pathophysiological roles, focusing particularly on their relevance in cardiac and skeletal muscle tissues.
The calpain system
Foundational calpain studies have focused on the mammalian m-and m-calpains, 15 which are thus called the conventional calpains; all other calpains are referred to as unconventional, and their structure is often described relative to that of the conventional calpains ( Figure 2 ).
Unifying the nomenclature for calpains and their domains
A unified calpain nomenclature was recently proposed based on a web-based discussion among calpain researchers, aiming to overcome hindered development of calpain studies due to complex naming. 4 This nomenclature defines mammalian calpain gene products as CAPN1, CAPN2, and so on; this follows the gene product nomenclature defined by the Human Genome Organization Gene Nomenclature Committee. To avoid confusion, this review refers to calpains by their proposed name followed by their previously common name, where applicable, in square brackets (e.g. Figure 2 ).
Calpain homologues
Although other papain superfamily proteases (clan CA) have weak local similarities to the CysPc domain, they are clearly differentiated from calpains by their low aa sequence similarity. Accordingly, the human genome has 15 calpain genes, and other mammals have nearly the same number. Calpain genes exist in almost all eukaryotes and a few bacteria, 1 and these non-mammalian calpains are also enormously interesting scientific subjects. In this review, we focus on mammalian calpains, which are classified by two criteria: structure and distribution. Non-classical calpains are divided into several subfamilies. The PalBH subfamily is the most evolutionarily conserved, being found from humans (CAPN7 [PalBH] ) to fungi (PalB) and yeast (Rim13[Cpl1]), but not in plants. 22 The PalB subfamily has two tandem C2L/C2 domains following the CysPc domain, and may have up to two microtubule interaction and trafficking (MIT) motifs at the N-terminus. The SOL subfamily is also evolutionarily conserved, with orthologues in almost all animal species, including humans (CAPN15[SOLH]), drosophila, and green algae. Its domain structure is characterized by several Zn 2+ -finger motifs and a specific SOL-homology (SOH) domain at the CysPc N-and C-termini, respectively ( Figure 2 In conditions such as cardiomyopathy, muscular dystrophies, or traumatic ischaemia, conventional calpain overactivation has been Figure 1 Major intracellular proteolytic systems. The ubiquitinproteasome system degrades and eliminates specific substrate proteins with an ubiquitin-tagging system consisting of .1000 ubiquitin ligases. The autophagy-lysosome system primarily degrades nonspecific cell components, including proteins and microorganisms, contained by isolation membranes. The caspase system (not shown) is a major intracellular proteolytic system with primarily apoptotic functions. 114 In contrast, calpains primarily elicit proteolytic processing, rather than degradation, to modulate or modify substrate activity, specificity, longevity, localization, and structure.
H. Sorimachi and Y. Ono identified as an aggravating factor, probably because the intracellular Ca 2+ homeostasis is compromised. 32 In such cases, attenuating symptoms by specifically inhibiting conventional calpains is a major objective. 33 In contrast, functional loss of a tissue-specific calpain can perturb the tissues in which it is expressed, as with muscular dystrophy and stress-induced gastric ulcers. 31,34 -36 Such systems might enable the identification of biological events in which calpain is important.
Calpain system regulatory components
The calpain system has two essential regulatory components, CAPNS1 [ 
Substrate specificity of calpains
Another classical research question is how calpains' substrate specificities are defined. The substrate specificities of the two conventional calpain species, CAPN1/S1[m-calpain] and CAPN2/S1[m-calpain], are almost indistinguishable. 63 Some preferences for calpain substrate sequences have been suggested, but a clear rule like that for caspases and trypsins is still elusive. To find such a rule, two major approaches were taken: a recursive method, comparing substrate cleavage-site sequences published thus far, and a deductive method using short oligopeptide libraries. 64 -66 Intriguingly, these methods drew somewhat different conclusions; the former studies found
′ sequence (|, cleavage site), 64 whereas the latter found 66 This difference may indicate that suboptimal sequences make better conventional calpain substrates because of their reduced reaction rates, a possible advantage for precise modulation by calpain-mediated proteolysis. 66 In a more recent approach, a prediction tool was constructed using bioinformatics, that is, to analyse experimental data by a machine learning process. 67 This assists our understanding of calpain-mediated proteolysis by predicting where the cleavage site, if any, is. This allows efficient speculation about possible functions mediated by calpain substrates. A draft version can be found at http://calpain.org. 67 5. Calpain function in the heart and skeletal muscles
The importance of proteolytic systems for maintaining cellular function is increasingly recognized; calpains are no exception. The
The calpain system in muscular disorders impact of calpain function depends on the particular substrates and conditions investigated, 68 -74 as illustrated by the calpain activity in skeletal and cardiac muscles.
Skeletal muscle homeostasis and CAPN3[p94]
The first tissue-specific calpain, the skeletal muscle-specific CAPN3[p94], was identified in 1989. 23 81 Intriguingly, mutations in MARP1 are found in some cases of dilated cardiomyopathy. 88 
Calpains in cardiovascular diseases
It was recently reported that calpain activity is necessary for cardiac cell function ( Table 1 and Figure 4) . However, as mentioned earlier, increased conventional calpain activity has often been reported as an aggravating factor in cardiovascular diseases and other pathophysiological conditions. Some of candidate calpain substrates related to cardiovascular system are shown in Table 2 .
Is calpain activity undesirable in the heart?
Many conditions that damage the cardiovascular system appear to be improved by inhibiting calpains. Contractile dysfunction after acute pressure overload, which was reported to be associated with calpain activation, is ameliorated by inhibiting calpains. 89, 90 Calpain activation, apoptosis, and the proteolysis of several substrates, including Bid and the SR proteins, have been reported in cardiac ischaemia or infarction. 91 -93 Again, inhibiting calpain activity ameliorates these pathological conditions. Diabetes-associated cardiovascular complications often result in morbidity and mortality. Heart-specific Capns1 disruption mitigated the myocardial hypertrophy and fibrosis in type 1 diabetes model mice. 94 In other words, knocking down both CAPN1/S1[m-calpain] and CAPN2/ S1[m-calpain] reduced the cardiac hypertrophy and fibrosis in these mice. Accordingly, inhibition of calpains by inhibitors and/or antisense nucleotides improved hyperglycaemia in streptozotocin-injected rats 95 and Zucker diabetic fatty rats, 96 animal models for type 1 and Table 1 .
The calpain system in muscular disorders S1[m-calpain], 99 and is also expressed to coronary arteries. Therefore, it is possible that inhibition of calpain ameliorates ACS, or at least suppresses acceleration of ACS. Another example of the involvement of calpain activity in cardiovascular disorders is myocardial stunning (also called broken-heart syndrome, stress/Takotsubo cardiomyopathy, or transient leftventricular apical ballooning), 100 which is a form of dysfunction caused by post-ischaemic reperfusion. Several reports point to proteolytic degradation of cardiac troponin I (cTnI) by calpain as a possible cellular mechanism underlying the depressed contractile function. 101, 102 There are, however, some controversial reports, demonstrating that no cTnI degradation was detected during porcine or canine myocardial stunning, 103, 104 and that myocardial-specific overexpression of CAPN1 [mCL] in Tg mice showed no clear cTnI degradation in the heart. 105 Although cTnI proteolysis probably affects myocardial contractile functions, 106 these counter-evidences suggest that cTnI degradation is not a cause but a result of ischaemia/reperfusion. Ischaemia/reperfusion causes calpain activation resulting in proteolysis of several proteins; however, it is still open to question which protein degradation is responsible for myocardial stunning. As discussed earlier, calpains have certain consensus for preferential sequences for substrates. 64, 66 Thus, if knock-in mice that have mutated sequence in the calpain cleavage sites of cTnI are generated, they will show whether or not cTnI degradation is essential for myocardial stunning as they only express cTnI mutant unproteolysed by calpains.
In addition to all of these findings, it has been proposed that calpains negatively impact these cardiovascular diseases by overproducing constitutively active PKCa. 107 global cardiac structure and function under normal conditions. However, when 10-week-old mice were subjected to pressure overload through transverse aortic constriction (TAC), the resulting fibrosis was significantly larger in the knockout than in the wild-type mice. Intriguingly, both knockout and wild-type mice developed cardiac hypertrophy, indicating that conventional calpain activity was not the primary cause of the TAC-induced hypertrophy. These knockout mice exposed to b-adrenergic stress through isoproterenol infusion developed cardiac dysfunction, again indicating the protective role of conventional calpains under stress. As also seen in cultured fibroblast cells, 73, 111 cardiomyocytes from the knockout mice showed defective membrane repair, 110 indicating that one of the conventional calpains' ubiquitous physiological functions relates to membrane repair. Another clue to protective/pathogenic roles of calpains may involve matrix metalloproteinase-2 (MMP-2). Historically, MMP-2 was considered to function on extracellular matrix substrates; however, several reports recently showed that the detrimental effect of MMP-2 may occur primarily within the myocytes. 112 Furthermore, MMP-2 targets a similar subset of proteins (including cTnI) as calpains, and, surprisingly, calpastatin may inhibit MMP-2 also. 112 Therefore, it is possible that at least part of bad reputation of calpains in cardiovascular disorders is responsible for MMP-2.
Conclusions and perspectives
Calpain's involvement in skeletal muscle and cardiovascular systems has been the subject of much interest and research. Many studies have shown that the activation of calpains, especially the conventional calpains, exacerbates pathophysiological conditions. However, recent technical advances have allowed us to delve deeper into the true nature of the calpain system. Genetic manipulations to disrupt Capns1 constitutively or conditionally in mice cause embryonic lethality 30, 38 and cardiac hypertrophy, 110 respectively, indicating that calpains are indispensable both to heart-specific functions and to life itself. In short, calpains are a double-edged sword: they are essential for various aspects of life, especially under stress conditions, yet their activation tends to be destructive in cells undergoing pathophysiological chaos.
In the process of revising this article, another review focusing on the role of calpains in multiple aspects of cardiovascular illness had come out. 113 As was discussed in the article as well as in this review, regulation of calpain activity stands as an important issue in developing therapeutic reagents for heart failure. In this respect, it should be noted that some pathological states may result from insufficient calpain activity. Genetic defects in tissue-specific calpains cause various diseases, which may be improved by activators or stabilizers for these calpains, and cardiovascular system and calpain functions therein would be no exception. One of the most urgent needs in this research field is the ability to detect real-time calpain activity in vivo at a high resolution for both physiological and pathophysiological conditions. As calpain research enters this new era, both basic science and translational biomedical studies are well positioned to launch comprehensive calpain studies.
